Liquidia Technologies to Present Data at Evolution of Next-Generation Sequencing Conference

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Sep 21, 2010 - Liquidia Technologies, Inc. today announced it will present new data at the Evolution of Next-Generation Sequencing Conference (www.healthtech.com/sqe) in Providence, Rhode Island, on September 27 -29, 2010. The poster entitled “PRINT® Technology: Enabling Next Generation Sequencing” will explore the unique features of PRINT particles and films and the potential they offer for next generation sequencing technologies including improved read accuracy, longer read lengths, faster reads, increased throughput and reduced cost.

The poster will be available during normal viewing sessions in the exhibition area.

Conference attendees unable to attend the poster sessions can find out more about Liquidia and the data being presented by visiting the Liquidia booth (Exhibit 27). For more information, visit the Liquidia website (www.liquidia.com) under “Product Platform/Publications” to download a PDF of the poster being presented.

Liquidia Technologies is developing precisely engineered particles for improved delivery of biological and small molecule drugs. Liquidia is advancing multiple programs internally and with corporate partners, the most advanced of which are vaccines products. The ability to control particle design parameters such as size, shape and composition is allowing Liquidia to address critical unmet needs in the prevention and treatment of human disease, as well as pursue follow-on opportunities such as the enhancement of gene sequencing. The company was founded in 2004 and is located in Research Triangle Park, North Carolina.

 

Contact: Liquidia Technologies, Inc.
Caroline Mishoe, 919-328-4416
caroline.mishoe@liquidia.com

 

 

Posted: September 2010

View comments

Hide
(web3)